Rezolute, Inc. (RZLT)
NASDAQ: RZLT · Real-Time Price · USD
2.560
+0.070 (2.81%)
At close: Mar 17, 2026, 4:00 PM EDT
2.580
+0.020 (0.78%)
After-hours: Mar 17, 2026, 7:39 PM EDT
Rezolute Market Cap
Rezolute has a market cap or net worth of $244.99 million as of March 17, 2026. Its market cap has decreased by -2.24% in one year.
Market Cap
244.99M
Enterprise Value
113.33M
1-Year Change
-2.24%
Ranking
Category
Stock Price
$2.56
Market Cap Chart
Since November 10, 2020, Rezolute's market cap has increased from $167.00M to $244.99M, an increase of 46.70%. That is a compound annual growth rate of 7.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 245.00M | 11.97% |
| Dec 31, 2025 | 218.80M | -22.93% |
| Dec 31, 2024 | 283.90M | 622.39% |
| Dec 29, 2023 | 39.30M | -48.43% |
| Dec 30, 2022 | 76.20M | 3.25% |
| Dec 31, 2021 | 73.80M | -26.27% |
| Dec 31, 2020 | 100.10M | -40.06% |
| Nov 10, 2020 | 167.00M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cellectis | 257.41M |
| Tenax Therapeutics | 254.87M |
| Coherus Oncology | 252.56M |
| Editas Medicine | 248.59M |
| Voyager Therapeutics | 247.34M |
| Alector | 243.90M |
| Nuvectis Pharma | 238.43M |
| Cybin | 235.17M |